532905 On Other Exchanges
Symbol
Exchange
532905 is not on other exchanges.

saamya biotech india ltd (532905) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SAAMYA BIOTECH INDIA LTD (532905)

Related News

No related news articles were found.

saamya biotech india ltd (532905) Related Businessweek News

No Related Businessweek News Found

saamya biotech india ltd (532905) Details

Saamya Biotech (India) Limited engages in the research and development of biotechnology products in India. It also trades in active pharmaceutical ingredients. The company has a collaboration agreement with European Technology Collaborator Company for technology transfer of fermentation products; and Arch Pharmalabs Ltd. for marketing of products. Saamya Biotech (India) Limited was incorporated in 2002 and is based in Hyderabad, India.

Founded in 2002

saamya biotech india ltd (532905) Top Compensated Officers

Chairman, Joint Managing Director and Chief F...
Total Annual Compensation: 300.0K
Managing Director, Chief Executive Officer, E...
Total Annual Compensation: 300.0K
Compensation as of Fiscal Year 2016.
saamya biotech india ltd
Saamya Biotech (India) Limited Announces Auditor Changes

An Extra Ordinary General Meeting (EGM) of Saamya Biotech (India) Limited was held on April 03, 2017. At the meeting the company announced that M. M. Reddy & Co. had appointed as statutory auditors of the company to fill the casual vacancy caused by the resignation of P. Murali & Co.

Saamya Biotech (India) Limited, Special/Extraordinary Shareholders Meeting, Apr 03, 2017

Saamya Biotech (India) Limited, Special/Extraordinary Shareholders Meeting, Apr 03, 2017, at 09:00 Indian Standard Time. Location: 104-106, Lumbini Enclave, Punjagutta Hyderabad, Telangana 500082 India Agenda: To consider the appointment of statutory auditor to fill casual vacancy caused by the resignation of statutory auditors.

Saamya Biotech (India) Limited Approves Address Change

Saamya Biotech (India) Limited announced that at the board meeting held on March 9, 2017, it has approved the change of registered office of the company from D. No. 6-1-61, Flat No. G-05, Mount Nasir Buildings, Beside Ravindra Bharathi, Near RBI, Saifabad, Khairatabad, Hyderabad - 500 004, Telangana, India to Suite 104-106, Lumbini Enclave, Opp. NIMS, Panjagutta, Hyderabad - 500 082, Telangana, India.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

532905 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 532905.
View Industry Companies
 

Industry Analysis

532905

Industry Average

Valuation 532905 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.3x
Price/Cash Flow 28.7x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SAAMYA BIOTECH INDIA LTD, please visit www.saamyabiotech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.